Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 1
1994 1
1995 1
1996 1
2000 4
2001 2
2002 1
2003 4
2004 5
2005 5
2006 9
2007 15
2008 13
2009 11
2010 13
2011 19
2012 25
2013 26
2014 25
2015 31
2016 32
2017 43
2018 42
2019 49
2020 57
2021 62
2022 82
2023 77
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

605 results

Results by year

Filters applied: . Clear all
Page 1
Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor That Potently Inhibits ROS1/TRK/ALK Solvent- Front Mutations.
Drilon A, Ou SI, Cho BC, Kim DW, Lee J, Lin JJ, Zhu VW, Ahn MJ, Camidge DR, Nguyen J, Zhai D, Deng W, Huang Z, Rogers E, Liu J, Whitten J, Lim JK, Stopatschinskaja S, Hyman DM, Doebele RC, Cui JJ, Shaw AT. Drilon A, et al. Among authors: zhai d. Cancer Discov. 2018 Oct;8(10):1227-1236. doi: 10.1158/2159-8290.CD-18-0484. Epub 2018 Aug 9. Cancer Discov. 2018. PMID: 30093503
CMTM6, a potential immunotherapy target.
Liang J, Li S, Li W, Rao W, Xu S, Meng H, Zhu F, Zhai D, Cui M, Xu D, Cai J, Zhang B. Liang J, et al. Among authors: zhai d. J Cancer Res Clin Oncol. 2022 Jan;148(1):47-56. doi: 10.1007/s00432-021-03835-9. Epub 2021 Nov 16. J Cancer Res Clin Oncol. 2022. PMID: 34783871 Review.
New Drugs for Hepatic Fibrosis.
Shan L, Wang F, Zhai D, Meng X, Liu J, Lv X. Shan L, et al. Among authors: zhai d. Front Pharmacol. 2022 Jun 13;13:874408. doi: 10.3389/fphar.2022.874408. eCollection 2022. Front Pharmacol. 2022. PMID: 35770089 Free PMC article. Review.
Therapeutic Prospects of Polysaccharides for Ovarian Cancer.
Wang K, Cai M, Sun S, Cheng W, Zhai D, Ni Z, Yu C. Wang K, et al. Among authors: zhai d. Front Nutr. 2022 Apr 7;9:879111. doi: 10.3389/fnut.2022.879111. eCollection 2022. Front Nutr. 2022. PMID: 35464007 Free PMC article. Review.
Caffeine in liver diseases: Pharmacology and toxicology.
Shan L, Wang F, Zhai D, Meng X, Liu J, Lv X. Shan L, et al. Among authors: zhai d. Front Pharmacol. 2022 Oct 17;13:1030173. doi: 10.3389/fphar.2022.1030173. eCollection 2022. Front Pharmacol. 2022. PMID: 36324678 Free PMC article. Review.
The role of the sex hormone-gut microbiome axis in tumor immunotherapy.
Wang L, Tang L, Zhai D, Song M, Li W, Xu S, Jiang S, Meng H, Liang J, Wang Y, Zhang B. Wang L, et al. Among authors: zhai d. Gut Microbes. 2023 Jan-Dec;15(1):2185035. doi: 10.1080/19490976.2023.2185035. Gut Microbes. 2023. PMID: 36880651 Free PMC article. Review.
The role of CXCL1/CXCR2 axis in neurological diseases.
Jiang S, Liang J, Li W, Wang L, Song M, Xu S, Liu G, Du Q, Zhai D, Tang L, Yang Y, Zhang L, Zhang B. Jiang S, et al. Among authors: zhai d. Int Immunopharmacol. 2023 Jul;120:110330. doi: 10.1016/j.intimp.2023.110330. Epub 2023 May 27. Int Immunopharmacol. 2023. PMID: 37247498 Review.
605 results